Backed by nongovernmental organizations and the generics industry, the left-of-center New Democratic Party has championed a bill that set out to improve Canada’s Access to Medicines Regime (CAMR), a law that enables drug manufacturers in the country to make generic medications for shipment to developing countries to treat illnesses such as tuberculosis and AIDS. The bill, C-393, was introduced to the… Read the rest
From Nature Medicine. Published online 7 January 2011.
In the last decade, the world’s drug regulatory agencies have approved dozens of new anticancer therapies for everything from lung carcinoma to skin melanoma. Some of these new drugs add months to a patient’s life. But others may offer only an extra week or two, on average, often with considerable toxicity and at a cost of thousands of dollars.
Now experts … Read the rest